The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice

Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways

(2013) Daniel F. Vatner et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Mechanisms for Insulin Resistance: Common Threads and Missing Links

(2012) Varman T. Samuel et al.   CELL

Thyroid Hormone Receptor Agonists Reduce Serum Cholesterol Independent of the LDL Receptor

(2012) Jean Z. Lin et al.   ENDOCRINOLOGY

Dissociating fatty liver and diabetes

(2012) Zheng Sun et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

New Powers of Brown Fat: Fighting the Metabolic Syndrome

(2011) Jan Nedergaard et al.   Cell Metabolism

Identical Gene Regulation Patterns of T3and Selective Thyroid Hormone Receptor Modulator GC-1

(2011) Chaoshen Yuan et al.   ENDOCRINOLOGY

Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis

(2011) Henriette E. Meyer zu Schwabedissen et al.   HEPATOLOGY

Brown adipose tissue activity controls triglyceride clearance

(2011) Alexander Bartelt et al.   NATURE MEDICINE

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Glycerol-3-Phosphate Acyltransferase 1 Deficiency in ob/ob Mice Diminishes Hepatic Steatosis but Does Not Protect Against Insulin Resistance or Obesity

(2010) A. A. Wendel et al.   DIABETES

A position statement on NAFLD/NASH based on the EASL 2009 special conference

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Minireview: Thyroid Hormone Transporters: The Knowns and the Unknowns

(2010) W. Edward Visser et al.   MOLECULAR ENDOCRINOLOGY

Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance

(2010) Miguel López et al.   NATURE MEDICINE

Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia

(2010) Paul W. Ladenson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats

(2009) Yongzhong Wei et al.   AMERICAN JOURNAL OF PATHOLOGY

Interference of a Mutant Thyroid Hormone Receptor α1 with Hepatic Glucose Metabolism

(2009) Milica Vujovic et al.   ENDOCRINOLOGY

Thyroid Hormone Induced Brown Adipose Tissue and Amelioration of Diabetes in a Patient with Extreme Insulin Resistance

(2009) Monica C. Skarulis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes

(2009) John D. Baxter et al.   NATURE REVIEWS DRUG DISCOVERY

Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver

(2009) L. P. Klieverik et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Causes and Metabolic Consequences of Fatty Liver

(2008) Norbert Stefan et al.   ENDOCRINE REVIEWS

Thyroid hormone (T3) and TRβ agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats

(2008) Andrea Perra et al.   FASEB JOURNAL

Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist

(2008) Edward E. Cable et al.   HEPATOLOGY

Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141

(2008) Galina Bryzgalova et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY